Jadin Heilmann

Stephen Meyn, MD, PhD

Bryn Webb, MD

 

Undiagnosed Disease Program Case Review

  • Examine the use of whole genome sequencing and optical genome mapping to identify novel variants that were not identified by whole exome sequencing. 
  • Define how new technologies can improve our understanding of the pathobiology of genetic disorders and the relationships between genomic variation and disease.
  • State the importance of in-depth phenotyping for rare diseases.
  • Identify a variety of tools and resources that can help diagnose patients.
Session date: 
10/23/2024 - 4:00pm to 5:00pm CDT
Location: 
Virtual
WI
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 CDR CPEUs
  • 1.00 NSGC Category 1 CEU Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Jadin Heilmann
Stephen Meyn, MD, PhD
Bryn Webb, MD